Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-03-08

FDA Approved: TOPIRAMATE — Supplemental Application (Aurobindo Pharma Limited)

View source ↗

Summary

FDA approved the supplemental application for Topiramate from Aurobindo Pharma Limited, confirming regulatory clearance for its generic Topiramate product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Topiramate (Topiramate)

Snippet

SUPPL AP for TOPIRAMATE (TOPIRAMATE)